中药逆转肝癌多药耐药的研究现状 |
| |
作者单位: | General Surgery,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China |
| |
摘 要: |
|
收稿时间: | 20 March 2004 |
The status of Chinese medicine in reversing multi-drug resistance of hepatocellular carcinoma |
| |
Authors: | Shengli Yang Yunxia Wang Xiaoli Pan Zhifan Xiong |
| |
Institution: | (General Surgery,Liyuan Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430077,China) ; |
| |
Abstract: | Multi-drug resistance (MDR) is a major obstacle in the chemotherapy of hepatocellular carcinoma. Comparing with western reversal
agents, traditional Chinese medicine have advantages of low cost, hypotoxicity, wide safety range, broad-spectrum and multi-targets,
etc. Therefore, traditional Chinese medicine may be expected to open up a new path to reverse MDR of liver cancer. Studies
about applying traditional Chinese medicine to reverse MDR in hepatocellular carcinoma are outlined below. |
| |
Keywords: | |
本文献已被 万方数据 SpringerLink 等数据库收录! |
|